Spire Wealth Management’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-148,800
| Closed | -$162K | – | 2496 |
|
|
2022
Q2 | $162K | Hold |
148,800
| – | – | 0.01% | 840 |
|
|
2022
Q1 | $158K | Buy |
148,800
+23,000
| +18% | +$24.4K | ﹤0.01% | 987 |
|
|
2021
Q4 | $113K | Buy |
125,800
+107,800
| +599% | +$96.8K | ﹤0.01% | 1353 |
|
|
2021
Q3 | $24K | Buy |
18,000
+4,000
| +29% | +$5.33K | ﹤0.01% | 1784 |
|
|
2021
Q2 | $27K | Buy |
14,000
+12,000
| +600% | +$23.1K | ﹤0.01% | 1750 |
|
|
2021
Q1 | $9K | Buy |
+2,000
| New | +$9K | ﹤0.01% | 2450 |
|